+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Hormonal Contraceptives Market 2024-2028 - Product Thumbnail Image

Hormonal Contraceptives Market 2024-2028

  • Report
  • November 2024
  • 169 Pages
  • Global
From
From
From
From
From
Metastatic Bone Disease - Global Strategic Business Report - Product Thumbnail Image

Metastatic Bone Disease - Global Strategic Business Report

  • Report
  • April 2026
  • 194 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 193 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • April 2026
  • 380 Pages
  • Global
From
From
From
From
From
From
From
From
Ewing Sarcoma Market - Global Strategic Business Report - Product Thumbnail Image

Ewing Sarcoma Market - Global Strategic Business Report

  • Report
  • April 2026
  • 377 Pages
  • Global
From
From
Loading Indicator